Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
Nona Biosciences to unveil its innovative AI-assisted drug discovery engine, Hu-mAtrIx: Cambridge, Massachusetts Monday, March 10, 2025, 17:00 Hrs [IST] Nona Biosciences, a global ...
Harnessing Harbour BioMed's proprietary HCAb-based bispecific antibody technology, �lanc� aims to develop innovative therapies addressing key challenges in current obesity treatment, including muscle ...
Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...
Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer’s Disease (AD); plans to initiate ...
Q32 Bio (QTTB) announced additional results from Part A of its SIGNAL-AA Phase 2a clinical trial of bempikibart in patients with alopecia ...
The Infectious Disease Society of America says there have been “no deaths related to the measles, mumps and rubella vaccine ...
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Amid the measles outbreak, which is expected to “expand rapidly,” an expert explains how to stay protected from the virus ...
New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...
Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 - - On track to report ...
Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback